NASDAQEquity ยท Daily Price and Trend

ANAB

AnaptysBio Inc

US Healthcare Biotechnology

52-week price+99.0%
Latest week
9 Oct 2026
Weekly close
45.95 USD
Fair value
25.19 USD
Next-week expectancy
Positive 55.49%

Current NASDAQ session

Delayed price and five-minute path

Finalizing sessionโ€ฆ Waiting for the settled close
Last price โ€”

โ€”

โ€”
Open
โ€”โ€”
High
โ€”โ€”
Low
โ€”โ€”
Previous close
โ€”Daily reference
Volume
โ€”Session to date
Todayโ€™s five-minute path
09:30โ€“16:00 EDT
Delayed market data. The chart shows five-minute prices from market open. Last updated โ€”

Seven-day news and sentiment ยท 7โ€“13 October 2026

Recent company news leans constructive

Positive company coverage has outnumbered negative coverage across the last seven days.

Open news and sentiment summary โ†’
Headlines ยท 7 days3
Publishers2
Headline balance2+ ยท 0โˆ’1 neutral
30-day weighted score56/100Neutral ยท Improved
Weekly anchor9 October 2026
Daily period12 Octโ€“12 Oct 2026
Completed sessions1

A new perspective begins when the next completed weekly update is published.

Price and trend

Price has held close to the latest weekly close

The daily path has softened without yet producing a decisive structural break.

Being tested since the weekly update

Move since weekly update

+0.20%

Latest completed daily close versus 45.95 USD.

Weekly view

Being tested

The daily path has softened without yet producing a decisive structural break.

Current position

Above the weekly close

Price location against the completed weekly reference points.

Participation

0.7ร— recent

Trading participation is broadly consistent with recent completed sessions.

Path quality

Developing

More completed sessions are needed to judge the shape of this weekโ€™s path.

Latest session

46.04

Indecisive session

Price since the weekly update

How the daily path is developing

Completed sessions only. The shaded area begins after the weekly anchor.

Up session Down session Current perspective Weekly closeTrend referenceCompleted supportCompleted resistance

Daily summary

What price and participation show

What supports it

Being tested

The daily path has softened without yet producing a decisive structural break.

What has changed

+0.20% since the update

The period has produced 1 completed session.

What could weaken it

Loss of completed support

A sustained move beneath completed support would materially weaken the developing position.

What to watch next

Above the weekly close; developing path

The next completed session will show whether price and participation reinforce or challenge the current direction.

Session progression

What happened each day

  1. Held steadyClosed near the session low
    46.04+0.20%

Other market evidence

What else has changed

Latest stored top-level readings; badges identify evidence updated since the weekly anchor.

OptionsNew

Bullish

ANAB shows bullish options pressure with a 48/100 conviction score, put-call volume ratio of 0.09, expected move of n/a, and Sharemaestro trend signal inactive.Open options โ†’

Short interest

Neutral

ANAB is classified as Neutral. Latest reported short interest is 5.2M shares; short interest changed -3.7%, price moved -5.3% between the weekly closes on or before the two settlements, short shares rank 60/100 within the comparable stored history, and days to cover ranks 50/100 within that history. Trend context is weak.Open short interest โ†’

Evidence context